Td Waterhouse Canada Inc. Gilead Sciences, Inc. Transaction History

Td Waterhouse Canada Inc.

$14.8 Trillion
Q2 2024

A detailed history of Td Waterhouse Canada Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Td Waterhouse Canada Inc. holds 41,354 shares of GILD stock, worth $3.64 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

41,354

Previous 41,409 0.13%

Holding current value

$3.64 Million

Previous $3.19 Billion 96.97%

% of portfolio

0.04%

Previous 0.02%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 02, 2024	SELL	$63.15 - $72.88 $3,473 - $4,008	-55 Reduced 0.13%	41,354 $6.28 Billion
Q1 2024 May 10, 2024	BUY	$71.58 - $87.29 $794,895 - $969,355	11,105 Added 36.65%	41,409 $3.19 Billion
Q4 2023 Feb 12, 2024	BUY	$73.27 - $83.09 $859,383 - $974,562	11,729 Added 63.14%	30,304 $2.78 Billion
Q3 2023 Nov 13, 2023	BUY	$73.94 - $80.67 $26,544 - $28,960	359 Added 1.97%	18,575 $2.04 Billion
Q2 2023 Nov 13, 2023	BUY	$76.01 - $86.7 $86,347 - $98,491	1,136 Added 6.65%	18,216 $1.47 Billion
Q1 2023 Nov 13, 2023	SELL	$77.31 - $88.08 $1.7 Million - $1.94 Million	-22,029 Reduced 56.33%	17,080 $1.56 Billion
Q4 2022 Nov 13, 2023	SELL	$62.32 - $89.47 $1.75 Million - $2.51 Million	-28,050 Reduced 41.77%	39,109 $4.14 Billion
Q3 2022 Nov 13, 2023	SELL	$59.54 - $68.01 $1.08 Million - $1.23 Million	-18,157 Reduced 21.28%	67,159 $3.67 Billion
Q2 2022 Nov 13, 2023	BUY	$57.72 - $65.01 $1.39 Million - $1.56 Million	24,031 Added 39.21%	85,316 $5.83 Billion
Q1 2022 Nov 13, 2023	SELL	$57.92 - $72.58 $96,263 - $120,627	-1,662 Reduced 2.64%	61,285 $5.08 Billion
Q4 2021 Nov 13, 2023	BUY	$64.88 - $73.64 $4.08 Million - $4.64 Million	62,947 New	62,947 $4.83 Billion

Others Institutions Holding GILD

# of Institutions

1,890

Shares Held

1.02B

Call Options Held

12M

Put Options Held

8.96M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Waterhouse Canada Inc., based on Form 13F filings with the SEC.

News

Stay updated on Td Waterhouse Canada Inc. with notifications on news.

Account

Td Waterhouse Canada Inc. Gilead Sciences, Inc. Transaction History